IL-22BP/IL22 RA2 Antibody [Alexa Fluor® 700]

• Reactivity: Hu
• Applications: WB
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Alexa Fluor 700

IL-22BP/IL22 RA2 Antibody [Alexa Fluor® 700] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human IL‑22BP
  Thr22-Pro231
  Accession # NP_851826
• Specificity: Detects human IL‑22BP in direct ELISAs and Western blots. In direct ELISAs, approximately 15% cross-reactivity with recombinant human IL‑22 R is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for IL-22BP/IL22 RA2 Antibody [Alexa Fluor® 700]

• class II cytokine receptor
• CRF2-10
• CRF2-S1IL22BP
• CRF2-X
• Cytokine receptor class-II member 10
• Cytokine receptor family 2 member 10
• Cytokine receptor family type 2, soluble 1
• IL-22 RA2
• IL-22 receptor subunit alpha-2
• IL22BP
• IL-22BP
• IL-22BPCRF2X
• IL22RA2
• IL-22RA2
• IL-22R-alpha-2
• interleukin 22 receptor, alpha 2
• interleukin 22-binding protein
• interleukin-22 receptor subunit alpha-2
• Interleukin-22-binding protein
• MGC150509
• MGC150510
• zcytoR16

Background

Interleukin 22 binding protein (IL-22BP), also known as cytokine receptor family (CRF) 2‑10, CRF2-X, and IL-22 RA2, is a secreted glycoprotein belonging to the type II cytokine receptor family. The IL-22BP gene has been localized to chromosome 6 near the gene for IFN-gamma R1. It encodes a precursor protein of 231 amino acid (aa) residues with a 21 aa putative signal peptide and five potential N-linked glycolsylation sites. IL-22BP lacks a transmembrane and cytoplasmic domain and is most closely related to the extracellular domains of IL‑22 R (CRF2-9) and IL-20 R (CRF2-8), sharing 33% and 34% aa sequence identity, respectively. It also shares sequence homology with the extracellular domains of IL-10 R (29%), IL-10 R beta (30%), the IFN receptors (23‑25%) and tissue factor (26%). IL-22BP antagonizes IL-22 activity by specifically binding IL-22 with high affinity and blocking its interaction with the cell surface IL-22 receptor heteromeric complex composed IL‑22 R and IL‑20 R. IL‑22BP is expressed in multiple tissues. The highest levels of expression are found in breast, lungs and colon.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.